Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Reid Pitts

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Urology|April 12, 2005
Re: osteoporosis and spinal fractures in men with prostate cancer: risk factors and effects of androgen deprivation therapyW Reid Pitts
The Journal of Urology|September 28, 2002
Re: Diethylstilbestrol revisited: androgen deprivation, osteoporosis and prostate cancerW Reid Pitts
The Journal of Urology|June 7, 2002
Re: Diethylstilbesterol revisited: androgen deprivation, osteoporosis an prostate cancerW Reid Pitts
The Journal of Urology|October 9, 2003
Re: Enhancement of diethylstilbestrol induced cytotoxicity by bcl-2 antisense oligodeoxynucleotides and a glutathione depletor for prostate cancerW Reid Pitts
The Journal of Urology|November 25, 2003
Re: Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancerW Reid Pitts
The Journal of Urology|July 13, 2004
Re: An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy seriesW Reid Pitts
The Journal of Urology|November 13, 2004
Re: the economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: findings from a retrospective analysis of health plan dataW Reid Pitts
BJU International|February 20, 2002
Prostatic intraepithelial neoplasia and putative precursor lesions of prostate cancer: a clinical perspectiveW Reid-Pitts
Urology|April 3, 2003
Newer approaches to androgen deprivation therapy in prostate cancerW Reid Pitts
The Journal of Urology|June 7, 2006
Re: The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledgeW Reid Pitts
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Urology|April 12, 2005
Re: osteoporosis and spinal fractures in men with prostate cancer: risk factors and effects of androgen deprivation therapyW Reid Pitts
The Journal of Urology|September 28, 2002
Re: Diethylstilbestrol revisited: androgen deprivation, osteoporosis and prostate cancerW Reid Pitts
The Journal of Urology|June 7, 2002
Re: Diethylstilbesterol revisited: androgen deprivation, osteoporosis an prostate cancerW Reid Pitts
The Journal of Urology|October 9, 2003
Re: Enhancement of diethylstilbestrol induced cytotoxicity by bcl-2 antisense oligodeoxynucleotides and a glutathione depletor for prostate cancerW Reid Pitts
The Journal of Urology|November 25, 2003
Re: Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancerW Reid Pitts
The Journal of Urology|July 13, 2004
Re: An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy seriesW Reid Pitts
The Journal of Urology|November 13, 2004
Re: the economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: findings from a retrospective analysis of health plan dataW Reid Pitts
BJU International|February 20, 2002
Prostatic intraepithelial neoplasia and putative precursor lesions of prostate cancer: a clinical perspectiveW Reid-Pitts
Urology|April 3, 2003
Newer approaches to androgen deprivation therapy in prostate cancerW Reid Pitts
The Journal of Urology|June 7, 2006
Re: The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledgeW Reid Pitts
Pageof 3